73 F
June 10, 2023
Image default

Pfizer says COVID-19 pill near 90% effective in final analysis

Published by

By Michael Erman and Deena Beasley NEW YORK (Reuters) -Pfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus. The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. The data disclosed on Tuesday includes an additional 1,…

Read More

Related posts

Oil rebounds as new Iran sanctions fuel more supply concerns


WHO chief scientist says Omicron ‘quite infectious’, must not panic


British lawmakers propose tightening parliament’s code of conduct rules


Dollar slips while Aussie and Norwegian crown outperform


Putin says peace talks with Ukraine are at dead end, goads the West


U.S. and UK to punish Putin’s elite friends if Russia invades Ukraine


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: